Alcanza Clinical Research completes acquisition of FDI Clinical Research to expand reach into Puerto Rico
Acquiring Company
Alcanza
Acquired Company
FDI Clinical Research
Description
Alcanza Clinical Research, a mission-focused investigator site network, has acquired FDI Clinical Research, a multi-specialty research organization based in San Juan, Puerto Rico. This acquisition accelerates Alcanza's ability to reach more patients and expand locations to offer more opportunities for clinical research as an extension of clinical care.
Quick answer
Alcanza is acquiring FDI Clinical Research, announced April 22, 2024. Alcanza is based in Lake Mary, Florida, United States.
- How much did Alcanza pay for FDI Clinical Research?
- The deal value was not disclosed.
- What does Alcanza do?
- Alcanza Clinical Research is a mission-focused investigator site network dedicated to reducing barriers to clinical research participation, especially in underrepresented patient populations.
- Where are Alcanza and FDI Clinical Research based?
- Alcanza is based in Lake Mary, Florida, United States. FDI Clinical Research is based in San Juan, Puerto Rico, United States.
- Who are the decision-makers at Alcanza?
- Fundz holds 1 contact at Alcanza. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Johnson & Johnson (J&J) completes $12.5 Billion Acquisition of Shockwave Medical to Strengthen Cardiac Health Solutions, $13B (April 5, 2024)
- Juvisé Pharmaceuticals acquires rights to MS therapy Ponvory outside North America (April 2, 2024)
- Harmony Biosciences acquires Epygenix Therapeutics, Inc. to expand rare epilepsy franchise (April 30, 2024)
- Bristol Myers Squibb completes acquisition of Karuna Therapeutics, Inc. to strengthen its neuroscience portfolio (March 18, 2024)
- Cycle Pharmaceuticals proposes to acquire Vanda Pharmaceuticals for $8.00 per share (June 6, 2024)
- AbbVie finalizes acquisition of Landos Biopharma, Inc. to advance treatment for ulcerative colitis and Crohn's disease (May 23, 2024)
Who to call at Alcanza, and when
When Alcanza changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Alcanza raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alcanza, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alcanza. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alcanza makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired FDI Clinical Research?
FDI Clinical Research was acquired by Alcanza, based in Lake Mary. The deal was reported on April 22, 2024. Alcanza Clinical Research is a mission-focused investigator site network dedicated to reducing barriers to clinical research participation, especially in underrepresented patient populations. Alcanza is privately held and operates in Biotechnology.
When did Alcanza acquire FDI Clinical Research?
Alcanza's acquisition of FDI Clinical Research was reported on April 22, 2024. Alcanza Clinical Research, a mission-focused investigator site network, has acquired FDI Clinical Research, a multi-specialty research organization based in San Juan, Puerto Rico. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does FDI Clinical Research do?
FDI Clinical Research is a state-of-the-art research facility and medical care clinic providing Phase I-IV clinical trials in support of biopharmaceutical sponsors and contract research organizations. It is privately held, operating in Biotechnology, and is based in San Juan.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.